Related Experiment Videos
Design and pharmacology of peptide mimetics
G J Moore1, J R Smith, B W Baylis
1Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada.
Advances in Pharmacology (San Diego, Calif.)
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99.
Journal of molecular graphics & modelling·2005
Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation.
Current medicinal chemistry·2005
Conformational and biological studies for a pair of novel synthetic AT1 antagonists: stereoelectronic requirements for antihypertensive efficacy.
Journal of pharmaceutical and biomedical analysis·2003
Discovery and design of novel inhibitors of botulinus neurotoxin A: targeted 'hinge' peptide libraries.
Journal of applied toxicology : JAT·2003
T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.
Advances in pharmacology (San Diego, Calif.)·2026
Tracking therapeutic T cells in vivo.
Advances in pharmacology (San Diego, Calif.)·2026
In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.
Advances in pharmacology (San Diego, Calif.)·2026
Transient T cell therapies.
Advances in pharmacology (San Diego, Calif.)·2026
Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.
Advances in pharmacology (San Diego, Calif.)·2026
Engineering T cell metabolism to enhance therapeutic efficacy.
Advances in pharmacology (San Diego, Calif.)·2026
Expanding Quantitative Medicines' Reach: Systems and Methods to Enhance R&D Productivity and Decision-Making in the Agentic-Era.
Clinical and translational science·2026
Physiologically Based Pharmacokinetic Modeling to Assess Transporter-Mediated Drug-Drug Interactions in Support of Labeling Recommendations for Zavegepant Nasal Spray.
Clinical pharmacology and therapeutics·2026
Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development.
Regulatory toxicology and pharmacology : RTP·2026
Structural determinants of Mac1 inhibition: Lessons from ligand binding patterns.
International journal of biological macromolecules·2026
A deep learning framework for oligopeptide candidate discovery across metabolism-related contexts.
Cell reports methods·2026
Structural basis of MRP2 interactions with substrate and inhibitor.
Structure (London, England : 1993)·2026